MTOR and cancer: The number of cancer cell lines with low expression of the TXNRD1 gene and mTOR p-Ser2448 protein that show a sensitivity (AUC < 0.9) to CDDP (29.9% and 24.03%) was higher compared to the cell lines with high expression of TRXR1 and mTOR p-Ser2448 (13.09% and 15.12% of cell lines) that are sensitive to CDDP.